Sequential serum galactomannan as outcome marker for invasive aspergillosis—An exploratory study from the FungiScope registry

Background: Galactomannan index (GMI) is established as a diagnostic tool for invasive aspergillosis (IA), while its utility in monitoring antifungal treatment (AFT) response and prognostic value remains unclear. This study evaluated the validity of serum GM as a biomarker for AFT monitoring and its...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Christina Többen, Oliver A. Cornely, Carolin S. Joisten, Ertan Sal, José A. Cozzi, Baptiste Hoellinger, Deniz Yilmaz Karapinar, Daniel Richter, Andreas H. Groll, Gustavo-Adolfo Méndez, Jeffrey D. Jenks, Nurettin Erben, Leyre López Soria, Philipp Koehler, Anna Apostolopoulou, Dries Deeren, Rika Draenert, Iker Falces-Romero, Julio Maquera-Afaray, Lisa Meintker, Ruwanthi Kolamunnage-Dona, Danila Seidel, Jannik Stemler
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-02-01
Colecção:	International Journal of Infectious Diseases
Assuntos:	Biomarker Immunocompromised host Treatment monitoring Registry study Invasive aspergillosis Galactomannan assay
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S1201971225004941
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!